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Abstract
Pancreatic cancer shows very poor prognosis and is the fifth leading cause of cancer death in Japan. Previous studies
indicated some genetic factors contributing to the development and progression of pancreatic cancer; however, there are
limited reports for common genetic variants to be associated with this disease, especially in the Asian population. We have
conducted a genome-wide association study (GWAS) using 991 invasive pancreatic ductal adenocarcinoma cases and 5,209
controls, and identified three loci showing significant association (P-value,5610
27) with susceptibility to pancreatic cancer.
The SNPs that showed significant association carried estimated odds ratios of 1.29, 1.32, and 3.73 with 95% confidence
intervals of 1.17–1.43, 1.19–1.47, and 2.24–6.21; P-value of 3.30610
27, 3.30610
27, and 4.41610
27; located on chromosomes
6p25.3, 12p11.21 and 7q36.2, respectively. These associated SNPs are located within linkage disequilibrium blocks
containing genes that have been implicated some roles in the oncogenesis of pancreatic cancer.
Citation: Low S-K, Kuchiba A, Zembutsu H, Saito A, Takahashi A, et al. (2010) Genome-Wide Association Study of Pancreatic Cancer in Japanese Population. PLoS
ONE 5(7): e11824. doi:10.1371/journal.pone.0011824
Editor: Wenjun Li, Duke University Medical Center, United States of America
Received May 7, 2010; Accepted July 3, 2010; Published July 29, 2010
Copyright:  2010 Low et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was conducted as a part of Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology
from the Japanese Government and Center for Genomic Medicine, RIKEN, Japan. It was also supported in part by the program for promotion of Fundamental
Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio). The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: Although the affiliations of the following three authors (Akira Saito [Statistical Genetics Analysis Division, StaGen Co., Ltd.], Suenori Chiku
[Science Solutions Division, Mizuho Information and Research Institute, Inc.] and Hirohiko Totsuka [Bioinfomatics Group, Research and Development Center,
Solution Division]) are in the private sector, each of them worked for one of the corresponding authors, Teruhiko Yoshida, as a part of a contract research solely
funded by an academic research fund granted from NiBio (http://www.nibio.go.jp/english/) to T. Yoshida. Therefore, this study neither received any funding from
the companies to which the above three authors belong, nor did their affiliating companies per se play any role in this research except that they sent their staff
(the above three authors) to the laboratory of Teruhiko Yoshida under a research contract paid by Yoshida’s grant. There is no competing interests involved
between Teruhiko Yoshida and these companies, including intellectual properties. The authors also confirm that they can adhere to all the PLoS ONE policies on
sharing data and materials.
* E-mail: yusuke@ims.u-tokyo.ac.jp (YN); tyoshida@ncc.go.jp (TY)
. These authors contributed equally to this work.
Introduction
Pancreatic cancer is the fifth leading cause of cancer death with
an estimated death of 24,634 patients in Japan in year 2007. Its 5-
year survival rate is as low as 6.7% (http://www.fpcr.or.jp/
publication/pdf/statistics2009/fig01.pdf and http://www.fpcr.or.jp/
publication/pdf/statistics2009/fig20.pdf). Since no specific symptom
is observed in the patients with pancreatic cancer at an early stage,
most of the patients were diagnosed at their advanced stage with a
very low possibility of cure for the disease [1,2].
Previous reports indicated the involvement of both environmen-
tal and genetics factors in the etiology of this deleterious disease.
Several case-control and cohort epidemiological studies have
identified a number of possible risk factors such as smoking [3],
diabetes [4], chronic pancreatitis [5], which are likely to predispose
individual to the disease. In addition, familial aggregation of the
disease has implied the possible involvement of genetic factors in
pancreatic cancer [6]; approximately 10% of the patients were
reported to have family history and individuals having first-degree
relatives with pancreatic cancer revealed 2- to 4- fold higher risk of
the disease [7–9]. These data indicated that genetic factors are likely
to play some roles in the development of pancreatic cancer. In the
last decade, the advancement of molecular biology improved the
understanding of the pathogenesis of pancreatic cancer and
characterized a number of genes that mutated in pancreatic
cancers, such as somatic mutations in genes INK4A(CDKN2A),
TP53, DPC4, BRCA1/2, STK11, APC, KRAS and ATM and PALB2
are found in pancreatic cancers [10–18].
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11824Two recent GWAS studies for pancreatic cancer using
Caucasian populations have identified associations with genome-
wide significance on chromosomes 9p34.2 (ABO), 13q22.1, 1q32
(NR5A2) and 5p15.33 (CLPTM1L-TERT), and highlighted that
accumulation of these common genetic risk variants with modest
effects are likely to play an important role on this complex disease,
either individually or in interaction with environmental factors
[19–22]. As the ethnicity is one of the critical factors in the
pathogenesis of the genetic diseases with complex gene-gene and
gene-environmental interactions, we (Biobank Japan (BBJ) in The
University of Tokyo and National Cancer Center (NCC) Japan)
combined samples of 991 cases with pancreatic cancer and 5209
controls (Table S1), attempted to identify common genetic
variations associated with susceptibility to pancreatic cancer in
the Japanese population.
Results
After the standard quality control of the genotype results (Table
S2), association analysis was performed for 420,236 SNPs using
logistic regression analysis on the basis of allelic, dominant and
recessive models after adjustment of age, sex and smoking status
for each individual. The Q-Q plot for this GWAS based on allelic
P-values by logistic regression revealed no significant population
stratification with genomic inflation factor l of 1.026 (Figure 1).
We successfully identified three genomic regions, 6p25.3,
12p11.21 and 7q36.2, shown to be significantly associated (P-
value,5.0610
27) with increased risk of pancreatic cancer in
Japanese population as indicated in the Manhattan plot in Figure 2
(referred to ref. 23).
The most significantly-associated SNP, rs9502893 (P-value of
3.30610
27, per-allele odds ratio (OR) of 1.29 with 95% confidence
interval (CI) of 1.17–1.43), is located within a 75-kb linkage
disequilibrium (LD) block on chromosome 6p25.3 (Table 1). This
LD block includes FOXQ1 (forkhead box (Fox) Q1) gene, which is
located 25 kb upstream to this marker SNP (Figure 3a). Imputation
analysis also revealed modest association at SNPs located near to or
on the FOXQ1 gene suggesting it to be one of the causative genes for
pancreatic cancer (Figure 3a and Table S3).
The second significantly-associated SNP, rs708224, located in
the second intron of the gene BICD1 (Bicaudal-D homolog 1) on
chromosome 12p11 (P-value of 3.30610
27, per-allele OR of 1.32
with 95% CI of 1.19–1.47) (Table 1). The 80-kb LD block showing
the association corresponds to the second intron of BICD1 as
revealed by the imputation analysis shown in Figure 3b (Table S3).
The third locus is marked by rs6464375, rs7779540, rs6973850
and rs1048768 in the first intron of DPP6 gene. These SNPs
indicated suggestive associations only under recessive model with
minimum P-value of 4.41610
27 (OR of 3.73 with 95%CI of 2.24–
6.21) as shown in Table 1 and Figure 3c.
Discussion
Here we present results of GWAS analysis on 991 cases with
pancreatic cancer and 5209 controls. Our study represents the first
GWASattempttoidentifycommonvariantsassociated withpancreatic
cancer in Japanese population and successfully identified SNPs located
on chromosomal loci of 6p25.3, 12p11.21 and 7q36.2 are significantly
associated with increased risk of pancreatic cancer in Japanese
population.
Figure 1. Q-Q plot for GWAS of pancreatic cancer in Japanese population. This Q-Q plot is based on logistic regression allelic P-values after
standard quality control. (genomic inflation factor l=1.026).
doi:10.1371/journal.pone.0011824.g001
GWAS Pancreatic Cancer Japan
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caused by the accumulation of common genetic variants, and each
of this variant has a very modest effect on the risk (for example OR
of ,1.2). In order to detect such small fraction, GWAS involving
much larger populations (5000–10000) should be required. Our
study was expected to identify SNPs with moderate effects (i.e
OR.1.4). Hence SNPs that show very modest effect might have
failed to be identified through this study.
The most significantly associated SNP in this GWAS, rs9502893
(P-value=3.30610
27, OR=1.29) is located within a 75 kb LD
block which encompasses gene FOXQ1 on chromosome loci 6p25.3.
FOXQ1 encodes for protein forkhead box (Fox) Q1. The Fox family
of transcription factors consists of at least 43 members and mutations
in Fox genes can cause significant effects on human common disease
and cancers [24,25]. A Fox member, FoxM1, is well-known to be
associated with oncogenesis of pancreatic cancer. Down-regulation
of this protein results in the inhibition of migration, invasion and
angiogenesis in pancreatic cancer cells [26]. Furthermore, a recent
study showed that FoxQ1 is overexpressed in pancreatic cancer,
suggesting its role in pancreatic cancer tumorigenesis [27]. Although
the SNP that we identified is approximately 25 kb downstream to
this gene, the associated SNP may ‘tag’ the causative variant located
on the expression regulatory region of the gene and subsequently
alter expression of the gene. However, further study is needed to
elucidate a precise biological role and mechanism of the gene
function with regard to pancreatic carcinogenesis.
The second most significantly associated SNP, rs708224 (P-
value=3.30610
27, OR=1.32) is located within the BICD1 gene.
This gene encodes a protein Bicaudal-D homolog 1, which plays a
role in vacuolar trafficking. Previous studies reported substantial
evidences indicating a link between vacuolar gene and shorter
telomeres in yeast model [28–30]. In addition, Mangino et al.
suggested that genetic variations within the BICD1 gene could alter
its transcriptional levels and in turn influence telomere length in
humans [31]. Several recent studies have documented reduced
telomere length in pancreatic ductal adenocarnoma specimens,
suggesting telomeric dysfunction in pancreatic cancer cells
[32–34]. Thus, it is of importance to determine the functional
consequences of rs708224 and/or variations linked to this SNP in
the pathogenesis of pancreatic cancer.
Several SNPs located in the first intron of DPP6 indicated
suggestive associations withan increased risk of pancreatic cancer in
this study. DPP6 encodes protein dipeptidyl-peptidase 6, which
binds to specific voltage-gated potassium channels and alters their
expression and biophysical properties. A recent study on core
signaling pathways in human pancreatic cancers found three
somatic mutations in DPP6 among 24 pancreatic cancer samples
examined by detailed sequence analyses. This report also suggested
that DPP6 might play a crucial role in regulation of invasion of
pancreaticcancer cells [35]. Hence, ourstudy strengthensthe risk of
DPP6 in pancreatic cancer and warrants further screening on this
gene to confirm its association with pancreatic cancer.
Recent GWAS reports have indicated several loci on chromo-
somes 9p34.2, 13q22.1, 1q32.1 and 5p15.33 to be associated with
an increased risk of pancreatic cancer in Caucasian population
[21,22]. Among the significantly associated SNPs, rs9543325 on
chromosome 13q22.1 showed moderate association in our study
populations (P-value (allelic model) of 1.69610
24; OR of 1.21 with
95%CI of 1.10–1.34) (Table S4). On the other hand, SNPs on
chromosomes 9p34.2 (rs505922) and 1q32.1 (rs3790844) showed a
weak association in our study populations (P-values of 3.69610
22
and 1.24610
22; ORs of 1.11 and 1.14 with 95% CI of 1.01–1.22
and 1.03–1.27, respectively) (Table S4). We wereunable to replicate
the remaining loci (SHH and two loci on chromosomes 5p15.33 and
15q14) in these reports, probably because most of these associated
SNPs are either non-polymorphic or possess very low allelic
frequencies (MAF=0.01) in Japanese population. The power of
ourstudywasnotsufficientenoughtodetectpositiveassociationsfor
Figure 2. Manhattan plot for GWAS of pancreatic cancer in Japanese population. The plot is based on logistic regression model after
correction of age, sex and smoking status. The Pmin indicates the minimum P-value from logistic regression analysis for three models: allelic, dominant
and recessive. Red line indicates genome-wide significant level (P-value=5610
27).
doi:10.1371/journal.pone.0011824.g002
GWAS Pancreatic Cancer Japan
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11824these variants with the low allelic frequency. Such ethnic difference
in genetic architecture of disease susceptibility is not rare. For
example, two recent GWAS reported common variants on KCNQ1
geneassociatedwithtype2diabetesmellitusinJapanesepopulation,
butEuropean GWASwereunable toidentifytheassociationsdueto
the low allelic frequency of these variants in the population [36,37].
In addition, identification of susceptibility loci may be also
influenced by the differences in the LD structure across different
populations and by potential interaction with other genetic variants
and environmental factors [38].
In summary, this study represents the first GWAS to identify
common variants possibly associated with pancreatic cancer in
Japanese population. Our study confirmed the association from the
Caucasian GWAS studies and revealed several novel possible
candidate associated loci that were not detected in the previous
Caucasian GWAS studies. Nevertheless, further additional replica-
tions are required to confirm or exclude the current findings.
Materials and Methods
Case and control subjects
A total of 331 and 675 cases that were clinically and/or
histologically diagnosed to have an invasive pancreatic ductal
adenocarcinoma were obtained from Biobank Japan (http://
biobankjp.org) at the Institute of Medical Science, The University
of Tokyo as well as National Cancer Center Hospital, respectively.
The control samples consisted of Japanese volunteers that were
obtained fromOsaka-MidosujiRotaryClub,Osaka,Japan (n=906)
as well as from staff members in Keio University, Japan, who
participated in its health-check program (n=677). In addition,
individuals who were registered in Biobank Japan as subjects with
various diseases except cancer (n=3,728) (those having pulmonary
tuberculosis, chronic hepatitis-B, keroid, drug-induced skin rash,
peripheral artery disease, arrhythmia, stroke and myocardial
infarction) were used as controls. All samples were obtained after
obtaining the written informed consent. This project was approved
by the ethics committee at The Institute of Medical Sciences, The
University of Tokyo, National Cancer Center and Keio University.
Individuals who had clinical history of diabetes mellitus (a possible
confounding factor for pancreatic cancer) were excluded from these
control sets. For sample quality control, we excluded five cases with
call rate,0.98. After performing principal component analysis, we
excluded outliers of 10 cases and 102 controls, who did not belong
to the major Japanese cluster (Hondo cluster) (Figure S1) [39]. We
eventually performed the association study based on 991 cases and
5209 controls (Table S1). Power calculation showed that our study
Figure 3. Regional association plots for three pancreatic cancer risk loci. (a) 6p25.3 region, SNP rs9502893 located 25 kb upstream to gene
FOXQ1. (b) 12p11.21 region, SNP rs708224 is located at the second intron of gene BICD1. (c) 7q36.2 region, SNP rs6464375 is located at the first intron
of gene DPP6 transcript variant 3. Each of the marker SNPs is marked by a blue diamond. SNPs that are genotyped in the Illumina platform are plotted
as diamonds; Imputed SNPs are plotted as circles. The color intensity reflects the extent of LD with the marker SNP, red (r
2$0.8), orange (0.5#r
2,0.8),
yellow (0.2#r
2,0.5) and white (r
2,0.2). Light blue line indicated local recombination rate.
doi:10.1371/journal.pone.0011824.g003
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PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11824would have over 90% power to detect a per-allele OR of 1.4 or
greater for an allele with 30% frequency at the genome-wide
significance level (a=5 610
27).
SNP genotyping and quality control
All the individuals were genotyped using either Illumina Infinium
HumanHap550v3 or Illumina Infinium Human610-Quad DNA
Analysis Genotyping BeadChip. SNPs common in the two
platforms were used for further analysis. We applied SNP quality
control for all sets of samples as follows; SNP call rate should be
.0.99 in both cases and controls, and P-value of Hardy-Weinberg
equilibrium test shouldbe .1.0610
26 incontrols.SNPs with minor
allele frequency (MAF) of ,0.01 in both case and control samples
were excluded from the further analysis (Table S2).
Statistical analysis
We analyzed each SNP using logistic regression adjusted for age
(continuous), sex and smoking status (current/former, never). P-
values and OR with 95%CI were calculated for allelic, dominant
and recessive models. We used the minimum P-values obtained
from three models to evaluate the statistical significance of the
association. All OR were reported with respect to the risk allele.
All the statistical analyses were performed using R statistical
environment version 2.9.0 (http://www.r-project.org/) or PLINK
1.06 (http://pngu.mgh.harvard.edu/ ˜purcell/plink/). R statistical
environment version 2.9.0 was employed to draw Q-Q plot and
regional association plot.
Genotype Imputation
We performed genotype imputation analysis for each set of
samples by utilizing a Hidden Markov model as programmed in
MACH version 1.0 (http://www.sph.umich.edu/csg/abecasis/
mach/index.html). To infer untyped and missing genotypes
around the candidate chromosomal loci, we provided genotypes
from our own samples together with haplotypes for reference
samples (Japanese from Tokyo, JPT) from HapMap database
(http://hapmap.ncbi.nlm.nih.gov/). SNPs with low genotyping
rate (,99%), showing deviations from Hardy-Weinberg equilib-
rium (,1.0610
26), or MAF (,0.01) were excluded from the
analysis. MACH version 1.0 was used to estimate haplotypes, map
crossover and error rates using 50 iterations of the Markov chain
Monte Carlo algorithm. By utilizing the genotype information
from the HapMap database, maximum likelihood genotypes were
generated. For quality control, we retained imputed SNPs with the
estimated r
2 of .0.3. We also picked up a total of 17 SNPs (P-
value,0.001) to verify the association using Invader and TaqMan
genotyping methods (data not shown).
Supporting Information
Table S1 Sample characteristic of this study.
Found at: doi:10.1371/journal.pone.0011824.s001 (0.02 MB
XLS)
Table S2 Total number of SNPs excluded according to each
quality control criteria.
Found at: doi:10.1371/journal.pone.0011824.s002 (0.02 MB
XLS)
Table S3 Imputation analysis around significantly associated
SNPs.
Found at: doi:10.1371/journal.pone.0011824.s003 (0.04 MB
XLS)
Table S4 Association study of SNPs which shown to be
significantly associated with increased risk of pancreatic cancer
in Caucasian population in Japanese.
Found at: doi:10.1371/journal.pone.0011824.s004 (0.02 MB
XLS)
Figure S1 Principal component analysis for GWAS of pancre-
atic cancer in Japanese population. a) Principal component
analysis for GWAS of pancreatic cancer in Japanese population
refer to four HapMap population control subjects including CEU
indicates Caucasians from Utah; YRI, Nigerians from Yoruba;
CHB, Han Chinese from Beijing and JPT, Japanese from Tokyo.
b) Principal component analysis of study subjects referred only to
Asian populations. We utilized samples from the homogenous
case-control (Hondo) cluster.
Found at: doi:10.1371/journal.pone.0011824.s005 (9.43 MB TIF)
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